Wolverine Stack

Not medical advice

Describes a named combination people search for — not a prescription. See the Disclaimer.

What It Is

The “Wolverine Stack” is the popular nickname for combining BPC-157 with TB-500 — a reference to the comic character’s rapid healing. It is the most-searched soft-tissue repair blend, targeting Joint & Tendon Repair and general Recovery from injury, with secondary interest in Muscle & Performance for training continuity.

  • BPC-157 — a stable synthetic pentadecapeptide studied (mostly in rodents) for tendon, ligament, muscle, and gut healing; short-acting and dosed frequently.
  • TB-500 — a synthetic Thymosin Beta-4 fragment (Ac-LKKTETQ) studied in animal/cell models for cell migration and tissue repair; longer-acting and dosed weekly.

The pairing is sold both as two separate vials and as a single pre-mixed “Wolverine” blend.

Why People Combine These

The rationale is mechanistic complementarity, not proven synergy:

  • Different proposed mechanisms. BPC-157 is associated with angiogenesis and growth-factor/NO-pathway signaling; TB-500 is associated with actin regulation and cell migration. The reasoning is that “local repair signaling” plus “systemic cell-migration support” covers more of the healing process than either alone.
  • Different dosing cadence. BPC-157’s short half-life suits daily dosing near an injury; TB-500’s longer action suits weekly dosing for systemic coverage — so they layer rather than overlap.

Evidence strength

There are no controlled human trials of this combination, and no published study testing BPC-157 + TB-500 together. Each component is itself Preclinical (animal/in-vitro) for repair, and the synergy claim is Anecdotal — extrapolated from single-compound animal data and user reports. See Side Effects & Risk Management.

Reported Dosing

As reported, not advice

Protocols below are as reported in community sources, not a clinical regimen. There is no established human therapeutic dose for either peptide or the blend. See Reconstitution & Dosing Math and Cycling.

ComponentReported doseFrequencyNotes
BPC-157~200–500 µg/day1–2× daily (SC)Often injected near the injury site; short half-life drives daily dosing
TB-500~2–2.5 mg, “loading”2× weekly (SC), ~4–6 weeksLonger-acting; loading phase
TB-500~2 mg, “maintenance”1× weekly (SC)After the loading phase

Typical reported run length is 4–6 weeks around an acute injury, then reassessment. See Cycling.

Combined Risks & Considerations

  • Stacked uncertainty. Combining two peptides with minimal human safety data compounds the unknowns rather than averaging them.
  • Shared theoretical concern. Both are pro-angiogenic / pro-migratory in preclinical work, so the speculative concern about effects on tumor growth applies to both — and is not characterized in humans.
  • WADA-banned. TB-500 (thymosin beta-4) is on the WADA Prohibited List (S2); tested athletes risk sanctions, and detection windows are reportedly long.
  • Injection-site and general reactions (irritation, fatigue, lightheadedness, nausea) are reported anecdotally for both.
  • Sourcing risk is doubled when buying a pre-mixed blend (see below).
  • See Side Effects & Risk Management.

Sourcing

This blend is frequently sold pre-mixed in a single vial, which adds risk: you cannot independently verify each peptide’s identity, ratio, or fill weight, and the TB-500 “full protein vs. 17–23 fragment” ambiguity is hidden inside the mix. Before trusting any product:

No vendors are endorsed here.

FAQ

Where does the name come from? From the comic character known for rapid healing — it is a community nickname, not a brand or medical term.

Is the Wolverine Stack proven to work? No. There are no human trials of the combination. Each peptide is supported mainly by animal data, and the synergy is anecdotal.

Buy it pre-mixed or as separate vials? Separate vials let you verify each peptide and adjust dosing independently; pre-mixed is convenient but harder to verify. See Sourcing and How to Read a CoA.

Can athletes use it? TB-500 is banned by WADA, so tested athletes should not — see TB-500.

References

  1. Chang C-H. et al. (2011). “The promoting effect of pentadecapeptide BPC 157 on tendon healing.” Journal of Applied Physiology.
  2. Gwyer D., Wragg N.M., Wilson S.L. (2019). “Gastric pentadecapeptide BPC 157 and its role in accelerating musculoskeletal soft tissue healing.” Cell and Tissue Research.
  3. Goldstein A.L., Hannappel E., Kleinman H.K. (2005). “Thymosin β4: actin-sequestering protein moonlights to repair injured tissues.” Trends in Molecular Medicine.
  4. World Anti-Doping Agency (WADA). Prohibited List — thymosin beta-4 (S2); current 2026 list.

Stacks · Home Educational information only — not medical advice. See Disclaimer.